Association américaine des industries du médicament (PhRMA)

Souscrire au flux RSS de cette rubrique

Histoire et composants dans cette catégorie

Article
31 December 2004
+ English - Cacher

Auteur: AccountAbility & Business for Social Responsibility

[refers to Merck, Novo Nordisk, Aspen Pharmacare, Grunenthal, Novartis, Citadel Aurobindo Biotech & Citadel Fine Pharmaceuticals (both part of Aurobindo Pharmaceuticals), Abbott Laboratories, Bristol Myers-Squibb, Pfizer, Schering-Plough, Eli Lilly...

Lire la suite

Article
1 October 2004
+ English - Cacher

Auteur: Francis Weyzig, SOMO (Centre for research on Multinational Corporations)

[Report provides overview of pharmaceutical sector, examines issues such as: Access to medicines; clinical trials; drug safety; drug promotion & advertising; indigenous knowledge; workplace health, safety, environment; employment conditions.] ...

Lire la suite

Article
26 August 2003
+ English - Cacher
Article
15 November 2001
+ English - Cacher

Auteur: UN Wire

...Even in light of the agreement allowing developing countries to break patents in the name of public health, the optimism of drug companies has not been dampened, the Wall Street Journal reports. "This does not change the way we sell our medicines,"...

Lire la suite

  • Entreprises concernées: Merck
Article
24 October 2001
+ English - Cacher

Auteur: PhRMA [Pharmaceutical Research and Manufacturers of America]

Typically working in partnership with local non-governmental organizations (NGOs), as well as international health and relief organizations, pharmaceutical companies are directly involved in improving public health...From 1998 through 2001, the...

Lire la suite

Article
16 October 2001
+ English - Cacher

Auteur: Consumer Project on Technology, Essential Action, Oxfam, Treatment Access Campaign & Health Gap

The following is a comment on two reports being circulated by the pharmaceutical industry regarding the importance of patents in Africa as a barrier to treatment for AIDS...The assertion in both documents is that patents are not an important barrier...

Lire la suite

Article
30 September 2001
+ English - Cacher

Auteur: PhRMA [Pharmaceutical Research and Manufacturers of America]

Lire la suite

Histoire
30 September 2001
+ English - Cacher
Article
10 September 2001
+ English - Cacher

Auteur: Susan Okie, Washington Post

About 12 of the world's most prominent medical journals are issuing a joint editorial this week stating that they will reject any scientific studies that do not come with an assurance that the sponsor -- whether a drug company or other organization --...

Lire la suite

Article
11 August 2001
+ English - Cacher